4 / 16
3
Q3 2015
Announced M&A Transactions
Completed
Completed
Completed
August 6, 2015
July 23, 2015
June 24, 2015
Notes
Notes
Notes
Mesa Laboratories Inc.
(NasdaqGS:MLAB) acquired
substantially all of the assets of North
Bay Bioscience, LLC from Michael E.
Kittendorf and Cynthia D. Kittendorf for
$11.3 million. Under the terms of the
agreement, the cash consideration of
$10.2 million was paid in cash at closing
and a future payment of $1 million plus
accrued interest from the date of closing
to the date of payment payable will be on
the first anniversary of the transaction’s
closing.
OptumRx, Inc. acquired Catamaran
Corporation (TSX:CCT) for $12.8 billion.
The agreement called for the acquisition
of Catamaran’s outstanding common
stock for $61.50 per share in cash.
UnitedHealth Group financed the
acquisition from existing cash resources
and new debt. Mark Thierer,
Catamaran’s former Chairman and
CEO, serves as CEO of OptumRx and
Timothy Wicks, the former CEO of
OptumRx, is President.
Zimmer Holdings, Inc. (NYSE:ZMH) acquired
LVB Acquisitions Inc (BioMet) from TPG Capital,
L.P., The Blackstone Group, Private Equity
Group, Goldman Sachs, Kohlberg Kravis
Roberts & Co. and others for $13.3 billion in
cash and stock. Zimmer changed its corporate
name to Zimmer Biomet Holdings, Inc. and
began trade on the New York Stock Exchange
and the SIX Swiss Exchange under the ticker
symbol ZBH.
acquired
acquired
acquired
Source: Public Filings; Industry Newswires and Capital IQ as of 9/16/15